+ All Categories
Home > Documents > Kara Nerenberg, MD, MSc , FRCPC Assistant Professor, University of Alberta

Kara Nerenberg, MD, MSc , FRCPC Assistant Professor, University of Alberta

Date post: 05-Jan-2016
Category:
Upload: kayla
View: 40 times
Download: 0 times
Share this document with a friend
Description:
Pregnancy-related diseases, their long-term health consequences and opportunities for interventions. Kara Nerenberg, MD, MSc , FRCPC Assistant Professor, University of Alberta. Objectives. - PowerPoint PPT Presentation
59
Pregnancy-related diseases, their long-term health consequences and opportunities for interventions. Kara Nerenberg, MD, MSc, FRCPC Assistant Professor, University of Alberta
Transcript
Page 1: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Pregnancy-related diseases,their long-term health consequences and opportunities for interventions.

Kara Nerenberg, MD, MSc, FRCPC

Assistant Professor, University of Alberta

Page 2: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Objectives

1. To understand the associations b/t pregnancy related diseases (preeclampsia & GDM) and future chronic diseases (vascular & renal).

2. To outline opportunities for interventions to reduce a woman’s risk of future chronic diseases.

Page 3: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Life-course model of pregnancy-associated diseases

•CAD•CVD•PAD•CKD

Chronic Diseases

•T2DM•HTN

Postpartum

• Gluc• Lipids• BMI• MA

•GDM•PEC

Pregnancy

• Gluc• Lipids• BMI•HTN•CKD

Pre-pregnancy

Offspring• T2DM• Obesity• Atherosclerosis

Page 4: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Questions to answer:

1. What chronic diseases do I need to look for? (awareness & screening)

2. Do we both have the same risk? (individualized risk assesment)

3. What can I do to prevent these chronic diseases? (prevention)

Page 5: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Preeclampsia

•CAD•CVD•PAD•CKD

Long-term Chronic Diseases

•T2DM•HTN

Postpartum

• Gluc• Lipids• BMI• MA

•GDM•PEC

Pregnancy

• Gluc• Lipids• BMI•HTN•CKD

Pre-pregnancy

A hypertensive disorder of pregnancy. BP ≥ 140/90 AND proteinuria ≥ 300 mg/24 hrs. 5-10% of all pregnancies maternal and fetal morbidity & mortality. A disease of maternal vascular endothelial dysfunction.

JOGC. 2008;30: S1-S48.

Page 6: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Preeclampsia Pathophysiology

Phase I Abnormal Placentation

Phase II Maternal Syndrome

Circulation. 2011;123: 2856-2869.Clin J Am Nephrol. 2007;2:543-549.

Page 7: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Preeclampsia Pathophysiology – Maternal Vascular Endothelium

Circulation. 2011;123: 2856-2869.

Page 8: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Endothelial dysfunction Atherosclerosis

1. http://www.robertsfox.com/EndoPAT.htm

Page 9: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Risk Factors for Preeclampsia

JOGC. 2008;30: S1-S48.

Page 10: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Resolution of HTN Post-PEC

Page 11: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Resolution of HTN Post-PEC

Page 12: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Resolution of Proteinuria Post-PEC

Page 13: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Resolution of Proteinuria Post-PEC

Page 14: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Am J Obstet Gynecol. 2009;200:58.e1-58.e8.

Page 15: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta
Page 16: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Preeclampsia and Chronic HTN

Am J Obstet Gyncol. 1986;155:1011-6.

Page 17: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Preeclampsia and Chronic HTN

BMJ. 2007; 974-977.

Page 18: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

T2DM:• PEC – 3.97 / 1000 • No PEC 2.21 / 1000

• HR: 1.82* (1.26, 2.62)

HTN in pregnancy. 2009;28:435-447.

Page 19: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Am J Kidney Dis. 2010;55:1026-1039.

Microalbuminuria* at 7.1 yrs PP:

PEC Severe PEC

4x 8x

* MA also with CVD

Page 20: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

NEJM. 2008;359:800-809.

Page 21: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Lancet. 2005; 366;1797-803.

Page 22: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Lancet. 2005; 366;1797-803.

Page 23: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

CV Outcome Study Risk 95% CI

Cardiac Disease Case-control (n=4)

OR: 2.47 1.22, 5.01

Cohort (n=10) RR: 2.33 1.95, 2.78

Cerebrovascular Cohort (n=6) RR: 2.03 1.54, 2.67

Peripheral Arterial Cohort (n=3) RR: 1.87 0.94, 3.73

CV Mortality Cohort (n=5) RR: 2.29 1.73, 3.04

Am Heart J 2008;145:918-930.

Metaregression Severity of Preeclampsia

Relative Risk 95% CI

Cardiac Disease Mild 2.00 1.83, 2.19

Moderate 2.99 2.51, 3.58

Severe 5.36 3.96, 7.27

P<0.0001.

Page 24: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

1

Preeclampsia & CVD:

Mild: 2.0 (1.8, 2.2)

Mod: 3.0 (2.5, 3.6)

Severe: 5.4 (4.0, 7.3)

Page 25: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Preeclampsia and CVD Death 14403 women:

481 PEC 244 CVD deaths

RF for CVD (HR): PEC – 2.14 (1.3-3.6) <34 wk – 9.54(4.5-20.3)

Survival at 30 yrs (56y) Early PEC – 85.9% Late PEC – 98.3% No PEC – 99.3%

Page 26: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Preeclampsia

Pregnancy CNS: Cerebral edema

Eclampsia / PRES CVS: HTN (severe)

CHF / MI Renal: Proteinuria

AKI Liver: Edema: AST/ALT

Hematoma / rupture Heme: HELLP

Thromboembolism

Post-partum

Stroke / CNS deficits ? Seizure disorder

Chronic HTN CAD/PAD cardiomyopathy

Microalbuminuria CKD / Dialysis

? Cirrhosis VTE Metabolic: Obesity,

T2DM, Dyslipidemia

Endo: hypothyroidism

Page 27: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Gestational Diabetes (GDM)1

•CAD•CVD•PAD•CKD

Long-term Chronic Diseases

•T2DM•HTN

Postpartum

• Gluc• Lipids• BMI•MA

•GDM•PEC

Pregnancy

• Gluc• Lipids• BMI•HTN•CKD

Pre-pregnancy

“Glucose intolerance with onset or first recognition during pregnancy”.

1. CDA. CPG 2008. Cdn J Diabetes. 2008;32:Suppl 1.

Page 28: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

GDM – Risk Factors

Age ≥ 35* Ethnicity*

Aboriginal Hispanic South Asian Asian African

FHx DM

Previous GDM Delivery of

macrosomic infant BMI ≥ 30* PCOS* Acanthosis Nigricans Corticosteroids

* Similar RF to preeclampsia

Page 29: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

1. CDA. CPG 2008. Cdn J Diabetes. 2008;32:Suppl 1.

Page 30: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

CMAJ. 2008;179:229-234.

Page 31: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Diabetes Care. 2008;31:1668-1669.

Page 32: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Normoglycemic

Mild: HR 1.19 (1.02-1.39)

GDM: HR 1.66 (1.30-2.13)

CMAJ. 2009; 181: 371-376.

Page 33: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Gestational Diabetes

Pregnancy GDM

Preeclampsia

Post-partum Type 2 Diabetes

Chronic HTN

CAD / CVD

Obesity

Dyslipidemia Microalbuminuria

Page 34: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Pregnancy and Future Disease

Circulation. 2011;123: 2856-2869.

Page 35: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

CV Risk Period CVD Risk Score

OR (95% CI) P-value

10-Year ≥ 5% 13.1 (3.4-85.5) <0.001

30-Year ≥ 10% 8.4 (3.5-23.2) <0.001

Lifetime ≥ 39% 3.3 (1.8-6.1) <0.001

(n=99 women with preeclampsia; n= 118 controls)

Page 36: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta
Page 37: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Interventions

•CAD•CVD•PAD•CKD

Long-term Chronic Diseases

•T2DM•HTN

Postpartum

• Gluc• Lipids• BMI• MA

•GDM•PEC

Pregnancy

• Gluc• Lipids• BMI•HTN•CKD

Pre-pregnancy

Offspring• T2DM• Obesity• Atherosclerosis

Page 38: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

No clear recommendations Adoption of “heart healthy” lifestyle

Page 39: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Part 2: Recommendations for Hypertension Treatment

2012 Canadian Hypertension Education Program Recommendations

From CHEP - http://www.hypertension.ca/chep-recommendations

Women with

Preeclampsia and GDM

Not Addresse

d

Page 40: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Women with

Preeclampsia and GDM

Not Addresse

d

Page 41: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Women with Preeclampsia

Not

Addressed

Page 42: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta
Page 43: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

SOGCPost-partum Recommendations

1. JOGC. 2008;30: S1-S48.

Page 44: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

SOGC Recommendations – Modified from CHEP 2008

1. JOGC. 2008;30: S1-S48.

Page 45: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Preeclampsia FoundationPost-partum Recommendations

Eat a heart healthy diet. Exercise 30 mins, 5 days

a week. Maintain a BMI 19-25. Stop smoking.

1. www.preeclampsia.org. Accessed on-line, Feb 29, 2012.

Page 46: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta
Page 47: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta
Page 48: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta
Page 49: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta
Page 50: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta
Page 51: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Post-partum Preeclampsia Interventions

Page 52: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Women appreciative of info received Women preferred:

Individualized counseling Ongoing monitoring of lifestyle

Balanced use of computer resources Flexibility in scheduling / Child care

Page 53: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

3 arms:1. Placebo2. Metformin 850 mg bid3. “Lifestyle” goals

- 7% weight loss- 150 mins activity

1. NEJM. 2002;346:393-403.2. Diabetes Care. 2007:30; S242-245.

Page 54: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

P: Pregnant women with GDM at Dx Otherwise healthy

I: “DEBI” lifestyle intervention (DPP) Diet, exercise and breastfeeding intervention Telephone & in person sessions (RD / Lact) Antenatal to 1 year post-partum

C: Usual care / lifestyle information O: 10 meet PP wt goal / 20 BF x 6/12 M: RCT

Diabetes Care. 2011;34: 1519-1525.

Page 55: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Results

Authors suggested: Earlier implementation of DEBI program To minimize Gestational wt gain (GWG)

Participants suggested: Physical Activity: Website

Support needed from family / social network Tips on exercising with a newborn

Diet: Low-fat recipes Tips on transitioning from diabetic diet.

Page 56: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Lessons from Lifestyle Programs

Pregnant / Post-partum women are interested and will participate.

Dietary education needs to be more comprehensive.

Specific physical activity advice. Website preferred mode of delivery. Awaiting results of Cochrane review of

Lifestyle interventions post GDM

Page 57: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Knowledge & Knowledge Translation %

Increased risk of chronic HTN with HDP ~ 50%

Specialist communicate this risk to patients ~ 60%

Specialist arrange for follow-up of BP ~ 60%

GP’s actually informed of C-HTN risk ~ 10%

Page 58: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Life-course model of pregnancy-associated diseases

•CAD•CVD•PAD•CKD

Chronic Diseases

•T2DM•HTN

Postpartum

• Gluc• Lipids• BMI• MA

•GDM•PEC

Pregnancy

• Gluc• Lipids• BMI•HTN•CKD

Pre-pregnancy

Offspring• T2DM• Obesity• Atherosclerosis

Page 59: Kara Nerenberg,  MD,  MSc ,  FRCPC Assistant Professor,  University of Alberta

Summary:

PE and GDM Context of a “life-course model”

Future maternal disease risk Vascular risk in offspring Recurrence in future pregnancies

Vascular RF monitoring & management Frequency unclear – “annual” Optimal targets unclear – “high risk” Lifestyle intervention counseling – first line

Extensive Research Opportunities


Recommended